Obesity Trial, Recruiting NCT06339840 Sponsor: Third Affiliated Hospital of Zhengzhou University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06339840
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men between the ages of 22 and 40 years old.
  • Men with a BMI of 30 or above (classified as obesity by World Health Organization standards).
  • Men who are willing and able to give informed consent and attend ongoing appointments at the Reproductive Center of the Third Affiliated Hospital of Zhengzhou University, including completing all required tests.
  • Men whose female partner is aged 20–40, has a regular menstrual cycle (cycle length of 21–35 days, lasting 2–7 days), has a BMI between 18.5 and under 25, and is planning to undergo assisted reproductive treatment (ART) at that centre due to male-related infertility.
  • Men who are not currently participating in, and have not participated in, any other research study in the past three months.
  • Men who agree to allow any children conceived through the study to take part in future follow-up research.

Who may not be able to join:

  • Men with known reproductive or urinary system conditions, such as active infections of the reproductive or urinary tract, low hormone production from the testes, high prolactin levels, excess oestrogen, or undescended testicles.
  • Men with acute or ongoing illnesses that could affect fertility, including serious long-term health conditions, a history of chemotherapy or radiation to the pelvis, or other acute illnesses that could affect the study results.
  • Men with digestive system or metabolic conditions, including gut diseases that affect nutrient absorption, a history of or current eating disorder, allergies to any ingredients in meal replacement products, gout, kidney stones, gallstones, or a history of weight loss surgery.
  • Men with certain lifestyle habits, including heavy alcohol use, daily smoking, a history of drug abuse, or a history of substance abuse.
  • Men who are unable to fully consent to participation, have a significant mental health condition, work in a role requiring intense physical activity, follow a diet that may interfere with the study's dietary plans, or who currently use or have previously used hormones, anti-obesity medications, or other drugs that affect hormone levels, carbohydrate metabolism, or appetite.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613608695579

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Third Affiliated Hospital of Zhengzhou University
Registry
ClinicalTrials.gov
Start date
20 June 2024
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov